Radiopharmaceuticals – a class of precision oncology medicines – are poised to transform the treatment of solid tumors. By hitching a radioisotope to a small molecule, these potent …

Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company focused on the discovery and development of novel radiopharmaceuticals for the treatment of a wide range of …

And that’s exactly what Radionetics is doing: the company’s knowledge of GPCR biology and small-molecular medicinal chemistry allows it to discover and develop novel small-molecule …

Oct 18, 2021 · Radionetics Oncology Announces Initiation of Phase 1 Radiopharmaceutical Program Against Novel Target for Adrenocortical Carcinoma

In this photo illustration, 'Radionetics Oncology' logo is being displayed on a mobile phone screen in Ankara, Turkiye on January 18, 2024. Get premium, high resolution news photos at Getty …

Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications, is poised to …

Oct 17, 2023 · Radionetics is advancing a pipeline of novel small molecule radioligands targeting G-protein coupled receptors for the treatment of a broad range of cancers, including …

Jul 1, 2024 · Radionetics is advancing a pipeline of novel small molecule radioligands targeting G protein coupled receptors for the treatment of a broad range of cancers, including breast …

Jan 27, 2025 · Website: https://radionetics.com Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

Oct 18, 2021 · Radionetics aims to develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment of a broad range of oncology indications. Radionetics’ …